Literature DB >> 21247890

Binding of Efb from Staphylococcus aureus to fibrinogen blocks neutrophil adherence.

Ya-Ping Ko1, Xiaowen Liang, C Wayne Smith, Jay L Degen, Magnus Höök.   

Abstract

In addition to its pivotal role in hemostasis, fibrinogen (Fg) and provisional fibrin matrices play important roles in inflammation and regulate innate immune responses by interacting with leukocytes. Efb (the extracellular fibrinogen-binding protein) is a secreted Staphylococcus aureus protein that engages host Fg and complement C3. However, the molecular details underlying the Efb-Fg interaction and the biological relevance of this interaction have not been determined. In the present study, we characterize the interaction of Efb with Fg. We demonstrate that the Fg binding activity is located within the intrinsically disordered N-terminal half of Efb (Efb-N) and that the D fragment of Fg is the region that mediates Efb-N binding. More detailed studies of the Efb-N-Fg interactions using ELISA and surface plasmon resonance analyses revealed that Efb-N exhibits a much higher affinity for Fg than typically observed with Fg-binding MSCRAMMs (microbial surface components recognizing adhesive matrix molecules), and data obtained from ELISA analyses using truncated Efb-N constructs demonstrate that Efb-N contains two binding sites located within residues 30-67 and 68-98, respectively. Efb-N inhibits neutrophil adhesion to immobilized Fg by binding to Fg and blocking the interaction of the protein with the leukocyte integrin receptor, α(M)β(2). A motif in the Fg γ chain previously shown to be central to the α(M)β(2) interaction was shown to be functionally distinguishable from the Efb-N binding site, suggesting that the Fg-Efb interaction indirectly impedes Fg engagement by α(M)β(2). Taken together, these studies provide insights into how Efb interacts with Fg and suggest that Efb may support bacterial virulence at least in part by impeding Fg-driven leukocyte adhesion events.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21247890      PMCID: PMC3059020          DOI: 10.1074/jbc.M110.199687

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Energetics of the HIV gp120-CD4 binding reaction.

Authors:  D G Myszka; R W Sweet; P Hensley; M Brigham-Burke; P D Kwong; W A Hendrickson; R Wyatt; J Sodroski; M L Doyle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

2.  A structural basis for complement inhibition by Staphylococcus aureus.

Authors:  Michal Hammel; Georgia Sfyroera; Daniel Ricklin; Paola Magotti; John D Lambris; Brian V Geisbrecht
Journal:  Nat Immunol       Date:  2007-03-11       Impact factor: 25.606

3.  Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999.

Authors:  D J Diekema; M A Pfaller; F J Schmitz; J Smayevsky; J Bell; R N Jones; M Beach
Journal:  Clin Infect Dis       Date:  2001-05-15       Impact factor: 9.079

4.  Fibrinogen promotes neutrophil activation and delays apoptosis.

Authors:  C Rubel; G C Fernández; G Dran; M B Bompadre; M A Isturiz; M S Palermo
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

5.  Cutting edge: members of the Staphylococcus aureus extracellular fibrinogen-binding protein family inhibit the interaction of C3d with complement receptor 2.

Authors:  Daniel Ricklin; Salome K Ricklin-Lichtsteiner; Maciej M Markiewski; Brian V Geisbrecht; John D Lambris
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

6.  Neutrophil degranulation mediates severe lung damage triggered by streptococcal M1 protein.

Authors:  O Soehnlein; S Oehmcke; X Ma; A G Rothfuchs; R Frithiof; N van Rooijen; M Mörgelin; H Herwald; L Lindbom
Journal:  Eur Respir J       Date:  2008-03-05       Impact factor: 16.671

7.  Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin alphaMbeta2 binding motif.

Authors:  Matthew J Flick; Christine M LaJeunesse; Kathryn E Talmage; David P Witte; Joseph S Palumbo; Malinda D Pinkerton; Sherry Thornton; Jay L Degen
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

Review 8.  Fibrinogen-binding proteins of Gram-positive bacteria.

Authors:  Jose Rivera; Ganesh Vannakambadi; Magnus Höök; Pietro Speziale
Journal:  Thromb Haemost       Date:  2007-09       Impact factor: 5.249

9.  Analysis of tight junctions during neutrophil transendothelial migration.

Authors:  A R Burns; R A Bowden; S D MacDonell; D C Walker; T O Odebunmi; E M Donnachie; S I Simon; M L Entman; C W Smith
Journal:  J Cell Sci       Date:  2000-01       Impact factor: 5.285

10.  Contribution of coagulases towards Staphylococcus aureus disease and protective immunity.

Authors:  Alice G Cheng; Molly McAdow; Hwan K Kim; Taeok Bae; Dominique M Missiakas; Olaf Schneewind
Journal:  PLoS Pathog       Date:  2010-08-05       Impact factor: 6.823

View more
  27 in total

Review 1.  Fibrinogen Is at the Interface of Host Defense and Pathogen Virulence in Staphylococcus aureus Infection.

Authors:  Ya-Ping Ko; Matthew J Flick
Journal:  Semin Thromb Hemost       Date:  2016-04-07       Impact factor: 4.180

2.  A structurally dynamic N-terminal helix is a key functional determinant in staphylococcal complement inhibitor (SCIN) proteins.

Authors:  Brandon L Garcia; Brady J Summers; Kasra X Ramyar; Apostolia Tzekou; Zhuoer Lin; Daniel Ricklin; John D Lambris; John H Laity; Brian V Geisbrecht
Journal:  J Biol Chem       Date:  2012-12-11       Impact factor: 5.157

3.  Nasopharyngeal colonization elicits antibody responses to staphylococcal and pneumococcal proteins that are not associated with a reduced risk of subsequent carriage.

Authors:  Sabine M P J Prevaes; Willem J B van Wamel; Corné P de Vogel; Reinier H Veenhoven; Elske J M van Gils; Alex van Belkum; Elisabeth A M Sanders; Debby Bogaert
Journal:  Infect Immun       Date:  2012-03-26       Impact factor: 3.441

Review 4.  The multifaceted role of fibrinogen in tissue injury and inflammation.

Authors:  James P Luyendyk; Jonathan G Schoenecker; Matthew J Flick
Journal:  Blood       Date:  2018-12-06       Impact factor: 22.113

5.  Staphylococcus aureus virulence is enhanced by secreted factors that block innate immune defenses.

Authors:  Ilse Jongerius; Maren von Köckritz-Blickwede; Malcolm J Horsburgh; Maartje Ruyken; Victor Nizet; Suzan H M Rooijakkers
Journal:  J Innate Immun       Date:  2012-02-07       Impact factor: 7.349

6.  Molecular characterization of endocarditis-associated Staphylococcus aureus.

Authors:  Cara Nethercott; Amanda N Mabbett; Makrina Totsika; Paul Peters; Juan C Ortiz; Graeme R Nimmo; Geoffrey W Coombs; Mark J Walker; Mark A Schembri
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

7.  The Staphylococcus aureus polysaccharide capsule and Efb-dependent fibrinogen shield act in concert to protect against phagocytosis.

Authors:  Annemarie Kuipers; Daphne A C Stapels; Lleroy T Weerwind; Ya-Ping Ko; Maartje Ruyken; Jean C Lee; Kok P M van Kessel; Suzan H M Rooijakkers
Journal:  Microbiology (Reading)       Date:  2016-04-25       Impact factor: 2.777

8.  Attenuation of Staphylococcus aureus-Induced Bacteremia by Human Mini-Antibodies Targeting the Complement Inhibitory Protein Efb.

Authors:  Maria Georgoutsou-Spyridonos; Daniel Ricklin; Haris Pratsinis; Eustathia Perivolioti; Ioannis Pirmettis; Brandon L Garcia; Brian V Geisbrecht; Periklis G Foukas; John D Lambris; Dimitrios C Mastellos; Georgia Sfyroera
Journal:  J Immunol       Date:  2015-09-04       Impact factor: 5.422

Review 9.  [Clinical symptoms and therapy of necrotizing skin and soft tissue infections].

Authors:  P Kujath; M Hoffmann; E Schlöricke; L Unger; R Bouchard
Journal:  Chirurg       Date:  2012-11       Impact factor: 0.955

Review 10.  Monoclonal Antibodies Targeting Surface-Exposed and Secreted Proteins from Staphylococci.

Authors:  Pietro Speziale; Giampiero Pietrocola
Journal:  Vaccines (Basel)       Date:  2021-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.